No abstract

We describe a very unusual presentation of misplaced Macroplastique injection. This incidentally showed up as bladder lesion and vaginal nodule during a tension-free vaginal tape surgery.

Objective To evaluate the efficacy of aspiration and sclerotherapy with 100% alcohol for the primary treatment of benign scrotal cysts. Methods From March 2014 to March 2018, 114 patients were identified who underwent their first aspiration and sclerotherapy procedure (80 hydroceles and 34 spermatoceles/epididymal cysts). The procedure was carried out in the outpatient clinic with local anaesthesia. A 16‐gauge IV catheter is used to puncture the sac under aseptic conditions. The volume of alcohol instilled was 10% of the aspirated volume (maximum of 50 mL). Patients were then observed in the waiting room and completed a questionnaire. Urology clinic follow up was scheduled at 6 weeks. Results At follow up, 54 patients (67.5%) with hydroceles and 25 patients (73.5%) with spermatoceles/epididymal cysts had resolution after a single procedure. A second procedure was offered if fluid collection persisted, of which 71% of patients with hydroceles and 100% of patients with spermatoceles/epididymal cysts had a successful outcome. At a median of 31 months post‐initial procedure, the overall success rate, after at most two procedures, was 80% for hydroceles and 85% for spermatoceles/epididymal cysts. The complication rate was low (6%). Almost all patients were happy to undergo the procedure again, if needed. Persistence following aspiration and sclerotherapy were more likely to occur in younger patients (45.4 versus 61.2 years, P = 0.001). Persistence was not related to the volume of fluid aspirated. Conclusion Aspiration and sclerotherapy with alcohol is a reliable, safe and effective technique for treatment of benign scrotal cysts.

No abstract

able amounts of blood loss. The total length of menstrual bleeding and the amount (number of tampons used) was reduced in all cases. One patient noted some intermenstrual spotting, but this was acceptable. The first two patients have been followed up for 11 and 16 months respectively and are alive and well, still with regular menstrual cycles and acceptable blood loss. The third patient was followed up for seven months and during this time had regular cycles with no side effects; four months after insertion she had a kidney transplant and three months later died from a massive gastrointestinal haemorrhage. The fourth patient was seen for nine months after IUD insertion; after five months she also had a kidney transplant and four months later died from pneumococcal pneumonia. These two deaths were not related to the IUD use. We conclude from this small series that the progesterone IUD offers definite advantages for patients undergoing haemodialysis who have heavy periods. In contrast to the use of systemic steroids intrauterine progesterone produces regular cycles with acceptable menstrual blood loss.